title: Time course for development of psoralen plus ultraviolet A erythema following oral administration of 5-methoxypsoralen.
authors.forename: L
authors.initials: L
authors.lastname: Berroeta
authors.forename: S
authors.initials: S
authors.lastname: Attili
authors.forename: A
authors.initials: A
authors.lastname: Wong
authors.forename: I
authors.initials: I
authors.lastname: Man
authors.forename: R S
authors.initials: RS
authors.lastname: Dawe
authors.forename: J
authors.initials: J
authors.lastname: Ferguson
authors.forename: S H
authors.initials: SH
authors.lastname: Ibbotson
mesh_terms: D000078223:5-Methoxypsoralen; D000328:Adult; D000368:Aged; D004890:Erythema / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008730:Methoxsalen / Q000009:adverse effects / Q000031:analogs & derivatives*; D008875:Middle Aged; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000009:adverse effects*; D011832:Radiation Injuries / Q000209:etiology; D013997:Time Factors; D055815:Young Adult
chemical_list: D017319:Photosensitizing Agents; D000078223:5-Methoxypsoralen; D008730:Methoxsalen